BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Hawaii Company PanThera Biopharma, Inc. Supports DoD Mission to Protect Forces Against Bioweapons


10/15/2009 8:00:27 AM

HONOLULU--(BUSINESS WIRE)--PanThera Biopharma announced today the award of a $1.6 M contract from the Department of Defense to advance the company’s research activities towards development of a small molecule antidote to treat botulism, which is a worldwide threat as the US fights the War on Terrorism. The one-year, $1.6M contract with the U.S. Army’s Telemedicine & Advanced Technology Research Center will enable PanThera to refine its proprietary drug discovery platform and accelerate the process for selecting preclinical drug candidates. Medical countermeasures against botulism are biodefense priorities for protecting both military and civilian populations against bioterrorism. PanThera’s small molecule antitoxins are designed to provide the improved manufacturability and stability needed to serve as a practical solution for acquisition into strategic stockpiles. Current biological products based on antibodies are available in limited supply, require cold storage and are very expensive. PanThera’s objective is to create a medical solution that is affordable, easy to use and store for stockpile for today’s warfighters and citizens.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->